Prestige Biopharma drug gets positive EMA opinion on Orphan Designation to treat pancreatic cancer Read more
EMA to review MAA for avalglucosidase alfa, enzyme replacement therapy to treat Pompe disease Read more
EMA approves label update for Takeda’s HYQVIA, expands use to treat secondary immunodeficiencies Read more